TNFSF10 and neoplasm: In the present review, we will describe TRAIL signaling and its regulation, as well as known mechanisms that contributed to cancer cell resistance to TRAIL therapy, and more importantly, will investigate the current approaches that resistance, ranging from combination therapy (using TRAIL along with other anti-tumor agents) to TRAIL targeted delivery by nanoparticles (NPs) and stem cells (SCs).